Arrowstreet Capital’s Omega Healthcare OHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-91,852
Closed -$3.74M – 1910
2024
Q3
$3.74M Buy
91,852
+85,842
+1,428% +$3.25M ﹤0.01% 1052
2024
Q2
$206K Buy
+6,010
New +$189K ﹤0.01% 1443
2022
Q3
– Sell
-79,489
Closed -$2.24M – 1413
2022
Q2
$2.24M Buy
+79,489
New +$2.26M ﹤0.01% 748
2022
Q1
– Sell
-442,685
Closed -$13.1M – 1453
2021
Q4
$13.1M Buy
+442,685
New +$12.9M 0.02% 582
2020
Q4
– Sell
-134,200
Closed -$4.02M – 2464
2020
Q3
$4.02M Buy
+134,200
New +$4.19M 0.01% 1250
2020
Q2
– Sell
-190,138
Closed -$5.05M – 2406
2020
Q1
$5.05M Buy
+190,138
New +$7.21M 0.01% 736
2017
Q3
– Sell
-12,700
Closed -$419K – 1190
2017
Q2
$419K Buy
+12,700
New +$420K ﹤0.01% 900
2016
Q3
– Sell
-433,300
Closed -$14.7M – 1580
2016
Q2
$14.7M Buy
433,300
+402,700
+1,316% +$13.4M 0.05% 344
2016
Q1
$1.08M Buy
+30,600
New +$1M ﹤0.01% 956
2015
Q3
– Sell
-23,000
Closed -$790K – 1454
2015
Q2
$790K Buy
+23,000
New +$845K ﹤0.01% 882
2014
Q1
– Sell
-21,708
Closed -$647K – 1281
2013
Q4
$647K Buy
+21,708
New +$688K ﹤0.01% 926

Other funds holding OHI

Arrowstreet Capital's OHI Position: Q4 2024 in Review

Arrowstreet Capital sold out of Omega Healthcare (OHI) in Q4 2024, closing a stake of 91,852 shares — an estimated $3.74M sold.

Arrowstreet Capital first reported a position in OHI in Q4 2013 and held it in 11 quarters. The position peaked at $14.7M in Q2 2016. 623 funds tracked by Wall St. Rank hold OHI as of Q4 2024.

  • Arrowstreet Capital reported no remaining Omega Healthcare position as of Q4 2024 after selling out during the quarter.
  • Arrowstreet Capital sold 91,852 Omega Healthcare shares in Q4 2024, an estimated $3.74M.
  • Arrowstreet Capital first reported a position in Omega Healthcare in Q4 2013 and held it in 11 quarters.
  • Arrowstreet Capital's Omega Healthcare position peaked at $14.7M in Q2 2016.
  • 623 funds tracked by Wall St. Rank held Omega Healthcare as of Q4 2024.

Based on Arrowstreet Capital's 13F filing for Q4 2024, filed 12 Feb 2025.